Merck Sues Over Medicare Drug-Price Negotiation Lawnews2023-06-06T18:41:33+00:00June 6th, 2023|The New York Times|
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeuticsnews2023-05-16T18:16:56+00:00May 16th, 2023|The New York Times|
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEPnews2023-05-09T17:34:57+00:00May 9th, 2023|The New York Times|
Supreme Court Ensures, for Now, Broad Access to Abortion Pillnews2023-04-22T14:39:23+00:00April 22nd, 2023|The New York Times|
Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Marketnews2023-04-19T20:30:08+00:00April 19th, 2023|The New York Times|
Supreme Court Could Restrict Abortion Pill Todaynews2023-04-19T13:04:44+00:00April 19th, 2023|The New York Times|
Appeals Court Says Abortion Pill Can Remain Available but Imposes Temporary Restrictionsnews2023-04-13T14:42:18+00:00April 13th, 2023|The New York Times|
Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authoritynews2023-04-10T07:00:09+00:00April 10th, 2023|The New York Times|
The Abortion Pill Ruling Is Bad Law, and the Biden Administration Should Fight Itnews2023-04-09T09:00:12+00:00April 9th, 2023|The New York Times|
Abortion Pill Cases Appear Headed to the Supreme Courtnews2023-04-09T08:27:00+00:00April 9th, 2023|The New York Times|
